LEADER 03619nam  2200553Ia 450 
001 9910806258203321
005 20230421044916.0
035   $a(CKB)1000000000450643
035   $a(EBL)3377556
035   $a(SSID)ssj0000215825
035   $a(PQKBManifestationID)11175812
035   $a(PQKBTitleCode)TC0000215825
035   $a(PQKBWorkID)10184959
035   $a(PQKB)10300463
035   $a(MiAaPQ)EBC3377556
035   $a(Au-PeEL)EBL3377556
035   $a(CaPaEBR)ebr10071745
035   $a(OCoLC)883573331
035   $a(EXLCZ)991000000000450643
100   $a20050321d1996      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aOptions for poliomyelitis vaccination in the United States$b[electronic resource] $eworkshop summary /$fVaccine Safety Forum, Division of Health Promotion and Disease Prevention, Institute of Medicine ; Cynthia J. Howe and Richard B. Johnston, editors
210   $aWashington, D.C. (2101 Constitution Ave., N.W., Washington 20418) $cNational Academy Press$d1996
215   $a1 online resource (50 p.)
300   $aDescription based upon print version of record.
311   $a0-309-57231-2 
320   $aIncludes bibliographical references.
327   $a""Options for Poliomyelitis Vaccination in the United States""; ""Copyright""; ""Preface""; ""Contents""; ""Introduction""; ""History and Current Status""; ""U.S. EXPERIENCE ""; ""Recent Experience""; ""Vaccine-Associated Paralytic Poliomyelitis""; ""EXPERIENCE IN OTHER PARTS OF THE AMERICAS""; ""Latin America""; ""Canada""; ""GLOBAL EXPERIENCE""; ""Options for Poliomyelitis Vaccination""; ""ORAL POLIOVIRUS VACCINE ONLY""; ""Vaccine Characteristics""; ""Current Use in the United States""; ""Immunity""; ""Safety""; ""INACTIVATED POLIOVIRUS VACCINE ONLY ""; ""Vaccine Characteristics""
327   $a""Current Use in the United States""""Immunity""; ""Safety""; ""IPV Experience in Western Europe""; ""General Comments""; ""SEQUENTIAL SCHEDULE FOR IPV AND OPV""; ""Public Health Experience""; ""Effect of a Sequential Series on the Occurrence of Vaccine-Associated Paralytic Poliomyelitis""; ""Immunogenicity and Shedding""; ""Summary""; ""PARENTAL CHOICE""; ""NO POLIO VACCINE ""; ""MODELING THE OPTIONS""; ""Vaccine-Associated Paralytic Poliomyelitis""; ""Susceptible Population""; ""Remaining Questions""; ""Discussion""; ""Afterword""; ""References""; ""Abbreviations""; ""Workshop Agenda""
327   $a""INSTITUTE OF MEDICINE VACCINE SAFETY FORUM""""History and Current Status of Poliomyelitis Vaccines""; ""Poliomyelitis Vaccine Characteristics""; ""Options for Poliomyelitis Vaccination""; ""CENTERS FOR DISEASE CONTROL AND PREVENTION""; ""Implementation Issues for Poliomyelitis Vaccination""; ""Considering the Options for Poliomyelitis Vaccination""; ""Discussion and Summary""; ""Workshop Speakers""; ""INSTITUTE OF MEDICINE AND CENTERS FOR DISEASE CONTROL AND PREVENTION""; ""Speakers and Session Chairs""
606   $aPoliomyelitis vaccine$zUnited States$vCongresses
606   $aPoliomyelitis$xPrevention$vCongresses
615  0$aPoliomyelitis vaccine
615  0$aPoliomyelitis$xPrevention
676   $a614.549
701   $aHowe$b Cynthia J$01085443
701   $aJohnston$b Richard B.$f1935-$01616165
712 02$aInstitute of Medicine (U.S.).$bVaccine Safety Forum.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910806258203321
996   $aOptions for poliomyelitis vaccination in the United States$94091483
997   $aUNINA